Takeda Sues Watson Over Sleeping Pill ANDA

Law360, New York (December 03, 2009, 3:22 PM ET) -- Takeda Pharmaceutical Co. Ltd. has launched an infringement action against Watson Pharmaceuticals Inc., opening a new front in its fight to block drugmakers from marketing a generic version of sleep medication Rozerem.

The complaint, filed Wednesday in the U.S. District Court for the District of Delaware, alleges Watson is seeking regulatory approval to manufacture and sell a treatment for insomnia that infringes Takeda’s patent rights.

Last month the defendant notified Takeda that it had submitted an abbreviated new drug application with the U.S. Food and Drug...
To view the full article, register now.